跳至主要内容
临床试验/NCT02887417
NCT02887417已完成不适用

Glioblastoma Platelet Activation Study

University Medicine Greifswald1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21
试验地点
1
主要终点
Mean P-selectine expression in all platelets

研究概览

简要总结

Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the most frequent immune cells in glioblastoma are tumor associated macrophages, which find theirself in an anti-inflammatory (M2) phenotype.

Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory status.

详细描述

Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the most frequent immune cells in glioblastoma are tumor associated macrophages, which find theirself in an anti-inflammatory (M2) phenotype.

Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory status.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • MR-morphological suspicion for glioblastoma
  • informed consent

排除标准

  • no informed consent

结局指标

主要结局

Mean P-selectine expression in all platelets

时间窗: 01/ 2016 - 10/ 2016

Mean CD63 expression in all platelets

时间窗: 01/ 2016 - 10/ 2016

Mean CD40 Expression in all platelets

时间窗: 01/ 2016 - 10/ 2016

Mean platelet-monocyte-conjugate formation in the monocyte population

时间窗: 01/ 2016 - 10/ 2016

次要结局

未报告次要终点

研究者

发起方
University Medicine Greifswald
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sascha Marx

Dr. med.

University Medicine Greifswald

研究点 (1)

Loading locations...

相似试验